PERSONALIS, INC.

Personalis, Inc. specializes in whole genome sequencing and advanced genomic analysis for precision health applications, leveraging high-throughput sequencing platforms and bioinformatics pipelines to deliver actionable insights from complex genomic data. Their core technical expertise lies in large-scale DNA sequencing, variant calling, somatic and germline mutation detection, and genomic data interpretation tailored for clinical and research use cases. The company differentiates itself through end-to-end workflow integration—from sample processing to data analysis—and a focus on scalable, reproducible genomic solutions that support longitudinal patient monitoring and population health studies. Their work emphasizes accuracy, data integrity, and compliance with clinical-grade sequencing standards. Personalis maintains a consistent and deep partnership with the Department of Veterans Affairs, delivering whole genome sequencing services that support veteran-specific health initiatives, including personalized treatment planning, cancer genomics, and inherited disease risk assessment. The recurring nature of these engagements suggests a trusted, operational relationship built on reliable delivery of genomic data critical to VA’s mission of improving veteran outcomes through precision medicine. The contractor’s primary industry focus is research and development in biotechnology, specifically in the application of genomic technologies to translational medicine. They operate at the intersection of clinical genomics and public health, positioning themselves as a specialized provider of genomic sequencing services for government-funded health research and veteran care programs. Their market niche is defined by technical rigor in non-nanobiotechnology genomic R&D, serving agencies that require high-complexity, clinically validated sequencing capabilities. Personalis, Inc. is a California-based entity structured as a limited liability company with no public certifications listed. Their geographic presence is centered in Fremont, CA, with a focused government market footprint aligned with federal health and research missions, particularly those requiring advanced genomic analysis infrastructure.